Asia-Pacific: Market for Medicaments Of Other Antibiotics 2022

Market Size for Medicaments Of Other Antibiotics in Asia-Pacific

In 2021, after two years of growth, there was significant decline in the Asia-Pacific medicaments of other antibiotics market, when its value decreased by -X% to $X. Over the period under review, consumption, however, saw a relatively flat trend pattern. The level of consumption peaked at $X in 2020, and then contracted in the following year.

Production of Medicaments Of Other Antibiotics in Asia-Pacific

In value terms, medicaments of other antibiotics production contracted to $X in 2021 estimated in export price. The total output value increased at an average annual rate of +X% from 2012 to 2021; the trend pattern indicated some noticeable fluctuations being recorded throughout the analyzed period. The pace of growth appeared the most rapid in 2017 when the production volume increased by X%. Over the period under review, production hit record highs at $X in 2020, and then reduced in the following year.

Exports of Medicaments Of Other Antibiotics

Exports in Asia-Pacific

Medicaments of other antibiotics exports surged to X tons in 2021, jumping by X% against the previous year. The total export volume increased at an average annual rate of +X% from 2012 to 2021; however, the trend pattern indicated some noticeable fluctuations being recorded throughout the analyzed period. As a result, the exports reached the peak and are likely to continue growth in the immediate term.

In value terms, medicaments of other antibiotics exports reduced slightly to $X in 2021. The total export value increased at an average annual rate of +X% from 2012 to 2021; however, the trend pattern remained consistent, with somewhat noticeable fluctuations in certain years. The pace of growth appeared the most rapid in 2020 with an increase of X% against the previous year. As a result, the exports attained the peak of $X, and then contracted in the following year.

Exports by Country

China represented the key exporter of medicaments of other antibiotics in Asia-Pacific, with the volume of exports reaching X tons, which was approx. X% of total exports in 2021. It was distantly followed by India (X tons), achieving an X% share of total exports. Japan (X tons) followed a long way behind the leaders.

China was also the fastest-growing in terms of the medicaments of other antibiotics exports, with a CAGR of +X% from 2012 to 2021. At the same time, India (+X%) displayed positive paces of growth. By contrast, Japan (-X%) illustrated a downward trend over the same period. While the share of China (+X p.p.) increased significantly in terms of the total exports from 2012-2021, the share of Japan (-X p.p.) and India (-X p.p.) displayed negative dynamics.

In value terms, India ($X), China ($X) and Japan ($X) appeared to be the countries with the highest levels of exports in 2021, together accounting for X% of total exports.

China, with a CAGR of +X%, saw the highest growth rate of the value of exports, in terms of the main exporting countries over the period under review, while shipments for the other leaders experienced mixed trends in the exports figures.

Export Prices by Country

In 2021, the export price in Asia-Pacific amounted to $X per ton, shrinking by -X% against the previous year. Over the period under review, the export price showed a perceptible shrinkage. The most prominent rate of growth was recorded in 2020 an increase of X%. As a result, the export price attained the peak level of $X per ton, and then shrank significantly in the following year.

There were significant differences in the average prices amongst the major exporting countries. In 2021, the country with the highest price was Japan ($X per ton), while China ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Japan (+X%), while the other leaders experienced mixed trends in the export price figures.

Imports of Medicaments Of Other Antibiotics

Imports in Asia-Pacific

In 2021, the amount of medicaments of other antibiotics imported in Asia-Pacific amounted to X tons, therefore, remained relatively stable against the year before. Overall, imports recorded a relatively flat trend pattern. The most prominent rate of growth was recorded in 2014 when imports increased by X%. The volume of import peaked at X tons in 2017; however, from 2018 to 2021, imports remained at a lower figure.

In value terms, medicaments of other antibiotics imports fell to $X in 2021. The total import value increased at an average annual rate of +X% from 2012 to 2021; the trend pattern indicated some noticeable fluctuations being recorded in certain years. The pace of growth appeared the most rapid in 2017 when imports increased by X%. The level of import peaked at $X in 2018; however, from 2019 to 2021, imports stood at a somewhat lower figure.

Imports by Country

Japan represented the major importing country with an import of about X tons, which finished at X% of total imports. China (X tons) took a X% share (based on physical terms) of total imports, which put it in second place, followed by Vietnam (X%), Thailand (X%), India (X%) and Malaysia (X%). The following importers - the Philippines (X tons), Indonesia (X tons), Myanmar (X tons), Australia (X tons), Taiwan (Chinese) (X tons), Pakistan (X tons) and Afghanistan (X tons) - together made up X% of total imports.

Imports into Japan decreased at an average annual rate of -X% from 2012 to 2021. At the same time, Indonesia (+X%), India (+X%), Malaysia (+X%), Taiwan (Chinese) (+X%), the Philippines (+X%), Vietnam (+X%), Afghanistan (+X%), Australia (+X%) and Myanmar (+X%) displayed positive paces of growth. Moreover, Indonesia emerged as the fastest-growing importer imported in Asia-Pacific, with a CAGR of +X% from 2012-2021. Pakistan, Thailand and China experienced a relatively flat trend pattern. From 2012 to 2021, the share of India, Indonesia, Malaysia and Vietnam increased by +X, +X, +X and +X percentage points, respectively. The shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, China ($X) constitutes the largest market for imported medicaments of other antibiotics in Asia-Pacific, comprising X% of total imports. The second position in the ranking was held by Japan ($X), with a X% share of total imports. It was followed by Vietnam, with a X% share.

In China, medicaments of other antibiotics imports increased at an average annual rate of +X% over the period from 2012-2021. In the other countries, the average annual rates were as follows: Japan (-X% per year) and Vietnam (-X% per year).

Import Prices by Country

The import price in Asia-Pacific stood at $X per ton in 2021, shrinking by -X% against the previous year. Over the period from 2012 to 2021, it increased at an average annual rate of +X%. The pace of growth was the most pronounced in 2018 an increase of X%. As a result, import price attained the peak level of $X per ton. From 2019 to 2021, the import prices remained at a lower figure.

Prices varied noticeably by the country of destination: the country with the highest price was China ($X per ton), while Myanmar ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by China (+X%), while the other leaders experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :